ChiCTR2400085952
尚未开始
/
/
/
2024-06-21
/
/
Loneliness
Supporting Current Home Care Services with a Robot-mediated Interactive Intervention (RMII) to Reduce Loneliness in Older Adults: A Feasibility and Pilot Randomized Controlled Trial
Supporting Current Home Care Services with a Robot-mediated Interactive Intervention (RMII) to Reduce Loneliness in Older Adults: A Feasibility and Pilot Randomized Controlled Trial
The study aims to assess the feasibility and acceptability of supplementing a robot-mediated interactive intervention (RMII) to current home care services in HK for older adults who live alone or with an older spouse at home, and to examine the preliminary efficacy of RMII on reducing loneliness. The objectives of the study are: 1. To assess the feasibility (recruitment rate, retention rate, intervention adherence, implementation fidelity, and safety) of RMII; 2. To assess the acceptability (participant satisfaction and usability of the features, cultural acceptance, electricity cost, etc.) of RMII; 3. To examine the preliminary efficacy of the RMII on loneliness, visuo-motor function, psychological distress, and quality of life among older adults.
随机平行对照
探索性研究/预试验
Participants will be randomly assigned to the IG or CG in a 1:1 ratio by an independent statistician using a computer program.
After receiving consent from the participant, a research assistant, who will be blinded to the group allocations, will collect demographic information and administer the baseline outcome measures (T0). This research assistant will again administer the outcome measures at week 2,4, 6, 8 and 3 months after the intervention through phone.
Health and Medical Research Fund (HMRF)
/
30
/
2024-04-01
2026-07-31
/
1) ethnic Chinese aged 60 years or above; 2) living alone or with an older spouse at home and receiving home care services); 3) with moderate or severe loneliness [score of 3-6 on the Chinese De Jong Gierveld loneliness scale]; 4) cognitively intact [score of ≦2 on the 5-item Abbreviated Memory Inventory for the Chinese (AMIC]; 5) able to command a robot by voice and use a hand to operate it on a surface pro.；
请登录查看1) those with diagnosis of a major neurocognitive disorder; 2) a history of symptomatic stroke or other disease of the central nervous system; 3) a serious medical or psychiatric illness (e.g., severe depression, schizophrenia, bi-polar disorder) or unremitting visual or hearing impairment that would interfere with using a robot; 4) have limited access to electricity and/or no Wi-Fi at home (as these are not favourable conditions for the use of technology).；
请登录查看the Hong Kong Polytechnic University
/
基石药业官微2026-02-16
一度医药2026-02-16
药明康德2026-02-16
医麦客2026-02-16
良医汇肿瘤资讯2026-02-15
国际眼科时讯2026-02-15
医麦客2026-02-15
药时空2026-02-15
石药集团2026-02-14
江苏康宁杰瑞生物制药有限公司2026-02-14
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
